|
BKNM-DP-183
N/A |
|
DSPE-TK-PEG-SH ¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-ͪ¿sÁò´¼-¾ÛÒÒ¶þ´¼-Ž€»ù
|
£¤Member visible
|
|
BKNM-DP-190
N/A |
|
DSPE-TK-PEG-COOHÁ×Ö¬-ͪ¿sÁò´¼-¾ÛÒÒ¶þ´¼--ôÈ»ù
|
£¤Member visible
|
|
BKNM-DP-182
N/A |
|
DPPE-PEG-OPSS ¶þר™°õ£Á×Ö¬õ£ÒÒõ£°·-¾ÛÒÒ¶þ´¼-à¶þÁòßÁà¤
|
£¤Member visible
|
|
BKNM-DP-180
N/A |
|
DSPE-PEG5000-NGR
|
£¤Member visible
|
|
BKNM-DP-179
N/A |
|
DSPE-PEG2000-psCPP ¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼2000-psCPP
|
£¤Member visible
|
|
BKNM-DP-177
N/A |
|
DSPE-TK-PEG-NHS
|
£¤Member visible
|
|
BKNM-DP-176
N/A |
|
DSPE-TK-PEG-MAL
|
£¤Member visible
|
|
BKNM-DP-175
N/A |
|
Tf-PEG-CDDP ÞDèFµ°°×-¾ÛÒÒ¶þ´¼-í˜ãK
|
£¤Member visible
|
|
BKNM-R-DZP018
N/A |
|
DSPE-Se-Se-PEG-NH2 ¶þÓ²Ö¬Ëáõ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-ëpÎøæI-°±»ù
|
£¤Member visible
|
|
BKNM-R-DZP017
N/A |
|
DSPE-Se-Se-PEG-MAL ¶þÓ²Ö¬Ëáõ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-ëpÎøæI-ñRíõ£†°·
|
£¤Member visible
|
|
BKNM-R-DZP016
N/A |
|
DSPE-Se-Se-PEG-NHS ¶þÓ²Ö¬Ëáõ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-ëpÎøæI-»îÐÔõ¥
|
£¤Member visible
|
|
BKNM-R-DZP015
N/A |
|
DSPE-Se-Se-PEG-COOH ¶þÓ²Ö¬Ëáõ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-ëpÎøæI-ôÈ»ù
|
£¤Member visible
|
|
BKNM-DP-172
N/A |
|
CuS@DSPE-PEG¶¨ÖÆ
|
£¤Member visible
|
|
BKNM-DP-171
N/A |
|
DSPE-PEG-SD¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-»Ç°·µØË÷ÐÁ
|
£¤Member visible
|
|
BKNM-DP-170
N/A |
|
DPPE-PEG-CDI ¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-N,N-̼õ£¶þßäßò
|
£¤Member visible
|
|
BKNM-DP-169
N/A |
|
DSPE-PEG-antagonist Gµ°°×¾ÛÒÒ¶þ´¼Á×Ö¬
|
£¤Member visible
|
|
BKNM-DP-168
N/A |
|
DSPE-PEG-FPBA ¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-3-ôÈ»ù-4-·ú±½ÅðËá
|
£¤Member visible
|
|
BKNM-DP-167
N/A |
|
DSPE-PEG-HC ¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-7-Áu»ùÏã¶¹ËØ
|
£¤Member visible
|
|
BKNM-DP-165
N/A |
|
DSPE-hyd-PEG-AA PHÃô¸ÐÐÍÖ¬Ù|ów
|
£¤Member visible
|
|
BKNM-DP-164
N/A |
|
DSPE-PEG-Nitrobenzofurazan Á×Ö¬-¾ÛÒÒ¶þ´¼-Ïõ»ù±½²¢ß»à«
|
£¤Member visible
|
|
BKNM-DP-163
N/A |
|
DSPE-PEG-IA Á×Ö¬-¾ÛÒÒ¶þ´¼-µâÒÒõ£°·
|
£¤Member visible
|
|
BKNM-DP-162
N/A |
|
DSPE-PEG-Alexa Fluor Á×Ö¬-¾ÛÒÒ¶þ´¼-AlexaFluorŸÉ¹âȾÁÏ
|
£¤Member visible
|
|
BKNM-DP-161
N/A |
|
Trastuzumab-PEG-DSPE ÇúÍ×Öé†Î¿¹-¾ÛÒÒ¶þ´¼-¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·
|
£¤Member visible
|
|
BKNM-DP-160
N/A |
|
DSPE-PEG-SWCNTs Á×Ö¬¾ÛÒÒ¶þ´¼Ì¼¼{Ã×¹Ü
|
£¤Member visible
|
|
BKNM-DP-159
N/A |
|
DSPE-PEG-SP2-AA¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-SP2-AA
|
£¤Member visible
|
|
BKNM-DP-158
N/A |
|
DSPE-PEG 2000-TM Á×Ö¬¾ÛÒÒ¶þ´¼-Ѫ˨Õ{¹µ°°×
|
£¤Member visible
|
|
BKNM-DP-157
N/A |
|
anti-HER2 scFv-PEG-DSPE †Î朿¹ówÖ¬Ù|ówÖÆ‚ä
|
£¤Member visible
|
|
BKNM-DP-156
N/A |
|
SPE-PEG-SG¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-SG
|
£¤Member visible
|
|
BKNM-DP-155
N/A |
|
DSPE-PEG-Thrombomodulin¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-¿¹ów
|
£¤Member visible
|
|
BKNM-DP-154
N/A |
|
DSPE-PEG-OVA¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-ova
|
£¤Member visible
|
|
BKNM-DP-153
N/A |
|
DSPE-PEG2000-PSP¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-PSP
|
£¤Member visible
|
|
BKNM-DP-152
N/A |
|
DSPE-PEG-Riboflavin¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-ºËüSËØ
|
£¤Member visible
|